## GEV: GE Vernova Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.4% below STRENGTH zone (4.0-10.0%); PEG 1.73 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($631.32)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Commonwealth Equity Services LLC Purchases 1,668 Shares of GE Vernova Inc. $GEV**
- Source: MarketBeat | 20260106T091431 | Somewhat-Bullish | Relevance: 100%
- Commonwealth Equity Services LLC increased its stake in GE Vernova Inc. by 1.3% in Q3, purchasing an additional 1,668 shares to bring its total holdings to 131,789 shares valued at approximately $81.0 million. This comes as GE Vernova posted Q3 revenues of $9.97 billion, exceeding expectations, though it missed EPS estimates. The company has also raised its quarterly dividend to $0.50, and institutional investors like Vanguard and State Street hold significant positions, contributing to a "Moderate Buy" analyst consensus.

**2. Behavioral Patterns of GEV and Institutional Flows**
- Source: Stock Traders Daily | 20260105T181200 | Bullish | Relevance: 100%
- This article analyzes Ge Vernova Inc. (NYSE: GEV) by providing insights into its near-term strong sentiment, mid-term neutrality, and long-term positive bias. It highlights specific trading strategies including position trading, momentum breakout, and risk hedging, along with detailed signal analysis across multiple timeframes. The report also points out an exceptional risk-reward short setup for GEV.

**3. Gateway Investment Advisers LLC Has $22.90 Million Stock Holdings in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20260104T122816 | Bullish | Relevance: 100%
- Gateway Investment Advisers LLC significantly reduced its stake in GE Vernova Inc. during Q3, selling 13,148 shares but still holding $22.90 million worth of stock. Despite the reduction, GE Vernova has seen a dividend increase and maintains a "Moderate Buy" consensus rating from Wall Street analysts with a target price of $691.11. Other institutional investors have also adjusted their positions, indicating varied activity around the stock.

**4. Fifth Third Wealth Advisors LLC Purchases 1,606 Shares of GE Vernova Inc. $GEV**
- Source: MarketBeat | 20260104T094309 | Bullish | Relevance: 100%
- Fifth Third Wealth Advisors LLC increased its stake in GE Vernova Inc. by 10.1% in Q3, acquiring 1,606 additional shares to reach a total of 17,573 shares valued at $10.8 million. The company reported mixed Q3 earnings, with EPS missing estimates but revenue exceeding expectations, and recently raised its quarterly dividend. Analysts maintain a "Moderate Buy" rating with an average price target of $691.11 for GEV shares.

**5. This CEO is trying to revive some of what made GE so special**
- Source: Fortune | 20260106T111016 | Bullish | Relevance: 84%
- GE HealthCare CEO Peter J. Arduini is working to restore key aspects of GE's original corporate culture, particularly its focus on leadership development and performance reviews, which he believes were stellar earlier in the company's history. This initiative comes as GE, once a massive conglomerate, has been split into three public companies, with GE HealthCare being one of them. Arduini aims to leverage the benefits of a focused, smaller company while retaining the valuable management practices from GE's past.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 9, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | RBC Capital | $761 | $761 | 0% |
| 2025-12-22 | Jefferies | $830 | $815 | +2% |
| 2025-12-18 | Jefferies | $815 | $736 | +11% |
| 2025-12-17 | Goldman Sachs | $840 | $735 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | RBC Capital | main | Outperform |
| 2025-12-22 | Jefferies | main | Buy |
| 2025-12-18 | Jefferies | up | Buy |
| 2025-12-17 | Goldman Sachs | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.6%)
- FMR, LLC: 8.4% (-8.5%)
- Blackrock Inc.: 7.4% (+1.8%)
- JPMORGAN CHASE & CO: 4.2% (+641.6%)
- State Street Corpora: 4.1% (+1.3%)

### Key Risks

1. High beta (2.64) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 9 raises (avg +10%) could attract flows.
- Momentum building: MRS_20 improving +1.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.73 elevated, pricing in significant growth expectations. Forward P/E 51.6x attractive for 73% earnings growth. Analyst sentiment positive (9 raises, avg +10%, $805 target (+17%)). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $186.8B |
| Beta | 1.00 |
| 52W Range | $252.25 - $731.00 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.73 |
| Forward P/E | 51.6 |
| Current P/E | 89.4 |
| YoY Growth | 73.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 0.8% to 2.4% (+1.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.6pp (needs >4.0% for momentum thesis). MRS_5 at 1.4% confirms short-term momentum alignment. AM_20 at 3.2% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.42% (CS: 63) | Neutral |
| RSI_14 | 60.3 | Neutral |
| MACD Histogram | -0.21 | Bearish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.118x | Above |
| vs SMA200 | 1.272x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $686.18
- **Stop Loss:** $631.32 (8.0% risk)
- **Target:** $741.04 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 24
- **Position Value:** $16,468.32
- **Portfolio %:** 16.47%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-01-21 (Est: $3.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.86 | $1.64 | -11.7% |
| 2025Q2 | $1.63 | $1.86 | +14.3% |
| 2025Q1 | $0.61 | $0.91 | +49.1% |
| 2024Q4 | $2.49 | $1.73 | -30.6% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*